Revati Shreeniwas

Revati Shreeniwas

President at
Revati, Inc.
65 year
Health Technology
Consumer Services
Commercial Services

Profile

Revati Shreeniwas is President at Revati, Inc. since 2004.
Also a Member at Continuing Medical Education, Inc. Former roles include Principal at Scios, Inc., CV Therapeutics, Inc., and The Trustees of Columbia University in The City of New York.
Served as Vice President-Clinical Research & Development at Alvine Pharmaceuticals, Inc. Vice President-Clinical Development at Soleno Therapeutics, Inc. from 2019 to 2020.
Professor at Stanford University.
Chief Medical Officer at NeurAxon Pharma, Inc. from 2015 to 2017 and at Bright Minds Biosciences, Inc. from 2020 to 2022.

Revati Shreeniwas active positions

CompaniesPositionStart
Corporate Officer/Principal -
Revati, Inc.
President 01/01/2004

Former positions of Revati Shreeniwas

CompaniesPositionEnd
BRIGHT MINDS BIOSCIENCES INC. Chief Tech/Sci/R&D Officer 01/12/2022
SOLENO THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 01/06/2020
Chief Tech/Sci/R&D Officer 01/01/2017
Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Revati Shreeniwas's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

4

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Health Technology

Revati, Inc.

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Revati Shreeniwas